Healthcare >> CEO Interviews >> October 5, 2000
THOMAS GLAZE is President and Chief Executive Officer of Metabolex, Inc.
He joined Metabolex in 1991 as a Founder, a Director and its Chief
Executive Officer. Prior to Metabolex, Mr. Glaze was a Founder of
Monoclonal Antibodies, Inc. and served as its Chairman and Chief
Executive Officer until its 1991 merger with Quidel Corp. He was
Chairman of Quidel until 1992 and remains a Director. Mr. Glaze holds an
MBA from Stanford University and a BIE from the Georgia Institute of
Technology. Profile
Mr. Glaze: Metabolex is a biotech company, and we actually refer to
ourselves as 'the diabetes biotech company.' Our mission
